Literature DB >> 2017878

A novel point mutation at codon 146 of the K-ras gene in a human colorectal cancer identified by the polymerase chain reaction.

S Orita1, T Higashi, Y Kawasaki, A Harada, H Igarashi, T Monden, H Morimoto, T Shimano, T Mori, J Miyoshi.   

Abstract

In this report, point mutations of the K-ras gene at codon 146 were analyzed in 25 cases of colon cancer, 4 cases of lung cancer, and 41 cases of lymphoid malignancy. A codon 146 mutation substituting threonine (ACA) for alanine (GCA) was detected in the tumor tissue of a patient with colon cancer and was not detected in the normal tissue of the same patient. Any additional mutations of the ras gene family were not detected in this patient. These results suggest that the codon 146 mutation of the K-ras gene could be involved in the development of naturally occurring human malignancies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017878     DOI: 10.1007/bf00571733

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  14 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21.

Authors:  A M de Vos; L Tong; M V Milburn; P M Matias; J Jancarik; S Noguchi; S Nishimura; K Miura; E Ohtsuka; S H Kim
Journal:  Science       Date:  1988-02-19       Impact factor: 47.728

4.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

5.  Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries.

Authors:  W I Wood; J Gitschier; L A Lasky; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

Review 6.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

8.  Hamster cell line suitable for transfection assay of transforming genes.

Authors:  T Higashi; H Sasai; F Suzuki; J Miyoshi; T Ohuchi; S Takai; T Mori; T Kakunaga
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 9.  The ras gene family and human carcinogenesis.

Authors:  J L Bos
Journal:  Mutat Res       Date:  1988-05       Impact factor: 2.433

10.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

View more
  6 in total

1.  Recurrent KRAS codon 146 mutations in human colorectal cancer.

Authors:  Sarah Edkins; Sarah O'Meara; Adrian Parker; Claire Stevens; Marcelo Reis; Siân Jones; Chris Greenman; Helen Davies; Gillian Dalgliesh; Simon Forbes; Chris Hunter; Raffaella Smith; Philip Stephens; Peter Goldstraw; Andrew Nicholson; Tsun Leung Chan; Victor E Velculescu; Siu Tsan Yuen; Suet Yi Leung; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Biol Ther       Date:  2006-08-01       Impact factor: 4.742

2.  Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors.

Authors:  Atsuo T Sasaki; Arkaitz Carracedo; Jason W Locasale; Dimitrios Anastasiou; Koh Takeuchi; Emily Rose Kahoud; Sasson Haviv; John M Asara; Pier Paolo Pandolfi; Lewis C Cantley
Journal:  Sci Signal       Date:  2011-03-08       Impact factor: 8.192

3.  High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.

Authors:  Jeffrey W Tyner; Heidi Erickson; Michael W N Deininger; Stephanie G Willis; Christopher A Eide; Ross L Levine; Michael C Heinrich; Norbert Gattermann; D Gary Gilliland; Brian J Druker; Marc M Loriaux
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

4.  Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine.

Authors:  G Smith; R Bounds; H Wolf; R J C Steele; F A Carey; C R Wolf
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

5.  p21X mRNA is expressed as a singly spliced pX transcript from defective provirus genomes having a partial deletion of the pol-env region in human T-cell leukemia virus type 1-infected cells.

Authors:  S Orita; H Kobayashi; Y Aono; A Saiga; M Maeda; H Igarashi
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

6.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.